Diagnostic Test: Mixed Meal Tolerance Test ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 298 | Hereditary pancreatitis | 1 |
298. Hereditary pancreatitis
Clinical trials : 98 / Drugs : 180 - (DrugBank : 57) / Drug target genes : 53 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03568630 (ClinicalTrials.gov) | July 26, 2018 | 13/6/2018 | Blood Markers of Early Pancreas Cancer | A Longitudinal Cohort Study to Identify Clinical and Blood Markers of Early Pancreas Cancer | Diabetes Mellitus, Type 2;PreDiabetes;Pancreas Cyst;Chronic Pancreatitis;Genetic Predisposition to Disease;Inherited Disease | Diagnostic Test: Mixed Meal Tolerance Test;Diagnostic Test: Hemoglobin A1c;Diagnostic Test: Other exploratory blood biomarkers | University of Nebraska | National Cancer Institute (NCI);Virginia Mason Hospital/Medical Center;VA Nebraska Western Iowa Health Care System | Recruiting | 19 Years | N/A | All | 1250 | United States |